WSBC Executive Purchases Preferred Depositary Shares in Underwritten Offering
Rhea-AI Filing Summary
Robert H. Friend, Executive Vice President & Chief Commercial Officer of WesBanco, Inc., reported a purchase of 800 depositary shares on 09/17/2025 at a price of $25.00 per depositary share. Each depositary share represents a 1/40th interest in a share of WesBancos 7.375% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B. The depositary shares were acquired in an underwritten public offering. The Form 4 was signed by an attorney-in-fact on 09/18/2025.
Positive
- Insider participation: An executive (EVP & CCO) purchased depositary shares, showing insider involvement in the offering.
- Transparent disclosure: Form 4 provides full transaction details including date, price ($25), and number of depositary shares (800).
- Clear explanation: Filing explains that each depositary share equals 1/40th of the Series B preferred and that shares were bought in an underwritten public offering.
Negative
- None.
Insights
TL;DR: Insider purchase of preferred depositary shares signals participation but is not materially dispositive for equity valuation.
The purchase of 800 depositary shares at $25 each by an executive indicates direct participation in the companys preferred issuance. Because each depositary share equals 1/40th of a preferred share, the underlying preferred interest is modest in absolute terms. The transaction was executed in an underwritten public offering, which implies a market-distribution process rather than a private placement. This disclosure is factual and routine for Section 16 reporting and provides transparency about insider holdings in the newly issued preferred series.
TL;DR: Filing appears complete and compliant; transaction documented as purchase via underwritten offering with attorney-in-fact signature.
The Form 4 reports the required details: reporting person identity and role, transaction date (09/17/2025), transaction code (P for purchase), number of depositary shares (800), price ($25), and an explanatory note linking depositary shares to the Series B preferred. The form is signed by an attorney-in-fact dated 09/18/2025. From a disclosure and Section 16 perspective, the form contains the expected elements and shows no obvious compliance omissions based on the provided content.